Terms: = Thyroid cancer AND DDIT3, CHOP, 1649, ENSG00000175197, _C/EBP zeta_, MGC4154, GADD153, CHOP10, P35638 AND Prognosis
5 results:
1. Primary thyroid lymphoma: a case series.
Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
[TBL] [Abstract] [Full Text] [Related]
2. TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma.
Bournaud C; Descotes F; Decaussin-Petrucci M; Berthiller J; de la Fouchardière C; Giraudet AL; Bertholon-Gregoire M; Robinson P; Lifante JC; Lopez J; Borson-Chazot F
Eur J Cancer; 2019 Feb; 108():41-49. PubMed ID: 30648628
[TBL] [Abstract] [Full Text] [Related]
3. Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma.
Olszewski AJ; Winer ES; Castillo JJ
Leuk Res; 2014 Aug; 38(8):866-73. PubMed ID: 24837081
[TBL] [Abstract] [Full Text] [Related]
4. [Malignant lymphoma of the thyroid].
Ohye H; Fukata S; Hirokawa M
Nihon Rinsho; 2007 Nov; 65(11):2092-8. PubMed ID: 18018576
[TBL] [Abstract] [Full Text] [Related]
5. [Malignant lymphoma of the thyroid gland].
Caparević Z; Stojanović D; Bojković G; Lalosević D; Stojanović M
Med Pregl; 2002; 55(11-12):485-9. PubMed ID: 12712891
[TBL] [Abstract] [Full Text] [Related]